Literature DB >> 8769489

BAL in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis.

V Tessier1, K Chadelat, A Baculard, B Housset, A Clement.   

Abstract

STUDY
OBJECTIVE: The development of BAL in children for both research and clinical purposes has been limited so far by the difficulty in establishing reference values. The aim of the study was (1) to define composition of BAL cellular components in control children and to evaluate the ability of these cells to express various cytokines, and (2) to study modifications of differential cytology and BAL cell cytokine responses in children with interstitial lung disorders. POPULATIONS AND METHODS: Two groups were investigated: a control group of 16 children who were concluded to be free of parenchymal lung disease after complete pulmonary investigation, and a group of 11 children with pulmonary sarcoidosis. Differential cytology was evaluated by standard techniques. BAL cell cytokine expression was studied at the level of messenger RNA (mRNA) by reverse transcription-polymerase chain reaction (RT-PCR) methods.
RESULTS: In the control group, differential cell counts appeared to be similar to values reported in adult populations with normal distribution of the data and no influence of age. In this group, no transcripts for interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), IL-6, and transforming (correction of tranforming) growth factor-beta (TGF-beta) could be detected. In children with sarcoidosis, different profiles of IL-1beta, TNF-alpha, IL-6, and TGF-beta expression were individualized which seemed to be related to the activity and/or severity of the disease, IL-6 and TGF-beta mRNA being observed only in the more severe forms.
CONCLUSION: These data provide information on BAL cell number and function in children. Characterization of BAL cytokine expression patterns during the course of interstitial lung diseases in children may be of great interest for evaluation of disease activity and/or severity and therefore for planning of therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769489     DOI: 10.1378/chest.109.6.1430

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

2.  Higher rate of bronchoalveolar lavage culture positivity in children with nonacid reflux and respiratory disorders.

Authors:  Rachel Rosen; Nikki Johnston; Kristen Hart; Umakanth Khatwa; Eliot Katz; Samuel Nurko
Journal:  J Pediatr       Date:  2011-07-21       Impact factor: 4.406

3.  A role for MCP-1/CCR2 in interstitial lung disease in children.

Authors:  Dominik Hartl; Matthias Griese; Thomas Nicolai; Gernot Zissel; Christine Prell; Dietrich Reinhardt; Dolores J Schendel; Susanne Krauss-Etschmann
Journal:  Respir Res       Date:  2005-08-11

Review 4.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.

Authors:  Hiroshi Kitazawa; Shigeo Kure
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-11

5.  Comparison of atopic and nonatopic children with chronic cough: bronchoalveolar lavage cell profile.

Authors:  Flavia de A Ferreira; Luiz Vicente F Silva Filho; Joaquim Carlos Rodrigues; Andrew Bush; Patricia L Haslam
Journal:  Pediatr Pulmonol       Date:  2007-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.